KR20090080941A - 전기천공법을 이용한 백신접종 및 부스팅을 사용하여 면역 반응을 강화시키는 방법들 - Google Patents

전기천공법을 이용한 백신접종 및 부스팅을 사용하여 면역 반응을 강화시키는 방법들 Download PDF

Info

Publication number
KR20090080941A
KR20090080941A KR1020097007135A KR20097007135A KR20090080941A KR 20090080941 A KR20090080941 A KR 20090080941A KR 1020097007135 A KR1020097007135 A KR 1020097007135A KR 20097007135 A KR20097007135 A KR 20097007135A KR 20090080941 A KR20090080941 A KR 20090080941A
Authority
KR
South Korea
Prior art keywords
tissue
administration
bolus
mammal
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097007135A
Other languages
English (en)
Korean (ko)
Inventor
이아콥 마티센
엘리자베스 토룬 티젤레
루네 크제켄
디에트마 라부세이
펑 린
Original Assignee
제네트로닉스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제네트로닉스, 인코포레이티드 filed Critical 제네트로닉스, 인코포레이티드
Publication of KR20090080941A publication Critical patent/KR20090080941A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020097007135A 2006-11-17 2007-11-16 전기천공법을 이용한 백신접종 및 부스팅을 사용하여 면역 반응을 강화시키는 방법들 Ceased KR20090080941A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85972406P 2006-11-17 2006-11-17
US60/859,724 2006-11-17

Publications (1)

Publication Number Publication Date
KR20090080941A true KR20090080941A (ko) 2009-07-27

Family

ID=39430332

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097007135A Ceased KR20090080941A (ko) 2006-11-17 2007-11-16 전기천공법을 이용한 백신접종 및 부스팅을 사용하여 면역 반응을 강화시키는 방법들

Country Status (8)

Country Link
US (1) US20100285040A1 (enExample)
EP (1) EP2091558B1 (enExample)
JP (1) JP5646851B2 (enExample)
KR (1) KR20090080941A (enExample)
CN (1) CN101522211A (enExample)
AU (1) AU2007322075B2 (enExample)
CA (1) CA2668649A1 (enExample)
WO (1) WO2008063555A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160047033A (ko) * 2014-10-21 2016-05-02 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148440A1 (en) 2009-06-24 2010-12-29 International Scientific Pty Ltd An apparatus and method of treatment utilizing a varying electromagnetic energisation profile
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US118956A (en) * 1871-09-12 Improvement in apparatus for the manufacture of extracts from hemlock and other
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
US6110161A (en) 1997-04-03 2000-08-29 Electrofect As Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6972013B1 (en) 1998-07-13 2005-12-06 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
EP1148885A4 (en) * 1999-02-08 2002-05-08 Chiron Corp ELECTRICALLY INDUCED INCREASE IN IMMUNITY AND EFFECTIVENESS OF IN VIVO DNA VACCINES
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
GB9922361D0 (en) * 1999-09-21 1999-11-24 Isis Innovation Generating an immune response to an antigen
ES2386884T3 (es) * 2000-11-01 2012-09-04 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vectores de expresión capaces de inducir respuesta inmunomejorada y métodos para usarlos
CA2478614C (en) 2001-03-13 2013-01-15 University Of South Florida Electromanipulation device and method
WO2003072016A2 (en) * 2001-11-19 2003-09-04 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
EP1474153A4 (en) * 2001-12-14 2005-12-14 Genetronics Inc PARTICLE-ASSISTED IMMUNIZATION METHODS BASED ON THE USE OF A PULSE ELECTRIC FIELD
US20060035853A1 (en) * 2004-01-07 2006-02-16 Biomedical Research Models, Inc. Methods for tailoring the immune response to an antigen or immunogen
EP1981581B1 (en) 2006-02-11 2016-04-13 Genetronics, Inc. Device for single-needle in vivo electroporation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160047033A (ko) * 2014-10-21 2016-05-02 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법

Also Published As

Publication number Publication date
WO2008063555A3 (en) 2008-11-06
EP2091558B1 (en) 2018-04-04
EP2091558A2 (en) 2009-08-26
WO2008063555A2 (en) 2008-05-29
JP5646851B2 (ja) 2014-12-24
US20100285040A1 (en) 2010-11-11
CA2668649A1 (en) 2008-05-29
AU2007322075A1 (en) 2008-05-29
AU2007322075B2 (en) 2013-07-25
JP2010510218A (ja) 2010-04-02
EP2091558A4 (en) 2012-07-04
CN101522211A (zh) 2009-09-02

Similar Documents

Publication Publication Date Title
JP7141063B2 (ja) 抗原およびアジュバントとしてのインターロイキン－２１を有するワクチン
EP1280550A2 (en) Electroporation for introduction of molecules into cells
Kisakov et al. The use of electroporation to deliver DNA-based vaccines
JP2003525912A (ja) 遺伝子送達用核酸製剤および使用方法
US20150004194A1 (en) Facilitator-dna combination vaccine
US20210353939A1 (en) Multiple Tissue Layer Electroporation Applicator and Device
WO2021178661A1 (en) Compositions containing a pathogenic antigen and an immune stimulator
Dobaño et al. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation
KR20090080941A (ko) 전기천공법을 이용한 백신접종 및 부스팅을 사용하여 면역 반응을 강화시키는 방법들
US11179458B2 (en) Immunogenicity of an optimized synthetic consensus DNA vaccine for porcine epidemic diarrhea virus
AU2013206520B2 (en) Methods of enhancing immune response using electroporation-assisted vaccination and boosting
IL302645A (en) Dna encoded nanoparticles and method of use thereof as a coronavirus disease 2019 (covid-19) vaccine
HK1135848A (en) Methods of enhancing immune response using electroporation-assisted vaccination and boosting
US20250255954A1 (en) Stabilized spike protein and method of use thereof as a coronavirus disease 2019 (covid-19) vaccine
WO2025038695A1 (en) Modified h3 hemagglutinin antigens and methods of use thereof
Edelblute Moderate Heat-Assisted Gene Electrotransfer for Intradermal DNA Vaccination and Protein Replacement Therapy in the Skin
WO2024182700A2 (en) Glycan modified sars-cov-2 glycoprotein nanoparticles and methods of use thereof
US20190307704A1 (en) Method for enhanced delivery of gene based therapy and vaccination using electroporation
JP2000004715A (ja) 脊椎動物への遺伝子導入発現方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090407

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120817

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140509

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20141218

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150321

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141218

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20140509

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I